Skip to main content
icon for Cyclosporiasis cases in U.S. by July 31?

Cyclosporiasis cases in U.S. by July 31?

icon for Cyclosporiasis cases in U.S. by July 31?

Cyclosporiasis cases in U.S. by July 31?

BARU
Jul 31, 2026
Polymarket

$1,409 Vol.

Polymarket

1800+

$164 Vol.

94%

2000+

$127 Vol.

92%

2500+

$821 Vol.

85%

3000+

$177 Vol.

66%

5000+

$120 Vol.

21%

This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.As of mid-July 2026, CDC surveillance shows the typical seasonal rise in cyclosporiasis cases driven by foodborne transmission of Cyclospora cayetanensis oocysts in contaminated fresh produce such as berries and leafy greens. Confirmed case counts remain consistent with historical summer patterns rather than indicating a large multistate outbreak, supporting trader focus on whether totals will exceed baseline thresholds by July 31. Key variables include import volumes, produce sourcing changes, and any new clusters identified through notifiable disease reporting. CDC's ongoing weekly or monthly updates on laboratory-confirmed cases will provide the next authoritative data releases that could shift market-implied odds.

This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
Volume
$1,409
Tanggal Berakhir
Jul 31, 2026
Pasar Dibuka
Jul 14, 2026, 9:55 PM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.As of mid-July 2026, CDC surveillance shows the typical seasonal rise in cyclosporiasis cases driven by foodborne transmission of Cyclospora cayetanensis oocysts in contaminated fresh produce such as berries and leafy greens. Confirmed case counts remain consistent with historical summer patterns rather than indicating a large multistate outbreak, supporting trader focus on whether totals will exceed baseline thresholds by July 31. Key variables include import volumes, produce sourcing changes, and any new clusters identified through notifiable disease reporting. CDC's ongoing weekly or monthly updates on laboratory-confirmed cases will provide the next authoritative data releases that could shift market-implied odds.

This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
Volume
$1,409
Tanggal Berakhir
Jul 31, 2026
Pasar Dibuka
Jul 14, 2026, 9:55 PM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.

Hati-hati dengan link eksternal.

Pertanyaan yang Sering Diajukan

"Cyclosporiasis cases in U.S. by July 31?" adalah pasar prediksi di Polymarket dengan 5 hasil yang mungkin di mana trader membeli dan menjual saham berdasarkan apa yang mereka yakini akan terjadi. Hasil terdepan saat ini adalah "1800+" di 94%, diikuti oleh "2000+" di 92%. Harga mencerminkan probabilitas crowd-sourced real-time. Misalnya, saham yang dihargai 94¢ menyiratkan bahwa pasar secara kolektif memberikan peluang 94% pada hasil tersebut. Peluang ini bergeser terus-menerus saat trader bereaksi terhadap perkembangan dan informasi baru. Saham dengan hasil yang benar bisa ditukarkan seharga $1 setiap saham saat pasar diselesaikan.

"Cyclosporiasis cases in U.S. by July 31?" adalah pasar yang baru dibuat di Polymarket, diluncurkan pada Jul 14, 2026. Sebagai pasar awal, ini adalah kesempatanmu untuk menjadi salah satu trader pertama yang menetapkan peluang dan membangun sinyal harga awal pasar. Kamu juga bisa menandai halaman ini untuk melacak volume dan aktivitas trading seiring pasar mendapatkan traksi.

Untuk trading di "Cyclosporiasis cases in U.S. by July 31?," jelajahi 5 hasil yang tersedia di halaman ini. Setiap hasil menampilkan harga saat ini yang mewakili probabilitas tersirat pasar. Untuk mengambil posisi, pilih hasil yang menurutmu paling mungkin, pilih "Ya" untuk mendukungnya atau "Tidak" untuk menentangnya, masukkan jumlahmu, dan klik "Trade." Jika hasil pilihanmu benar saat pasar diselesaikan, saham "Ya" kamu membayar $1 masing-masing. Jika salah, mereka membayar $0. Kamu juga bisa menjual sahammu kapan saja sebelum resolusi jika kamu ingin mengamankan keuntungan atau memotong kerugian.

Unggulan saat ini untuk "Cyclosporiasis cases in U.S. by July 31?" adalah "1800+" di 94%, yang berarti pasar memberikan peluang 94% pada hasil tersebut. Hasil terdekat berikutnya adalah "2000+" di 92%. Peluang ini diperbarui secara real-time saat trader membeli dan menjual saham, sehingga mencerminkan pandangan kolektif terbaru tentang apa yang paling mungkin terjadi. Cek kembali secara rutin atau tandai halaman ini untuk mengikuti bagaimana peluang bergeser saat informasi baru muncul.

Aturan resolusi untuk "Cyclosporiasis cases in U.S. by July 31?" mendefinisikan dengan tepat apa yang harus terjadi agar setiap hasil dinyatakan sebagai pemenang — termasuk sumber data resmi yang digunakan untuk menentukan hasilnya. Kamu bisa meninjau kriteria resolusi lengkap di bagian "Aturan" di halaman ini di atas komentar. Kami menyarankan membaca aturan dengan cermat sebelum trading, karena mereka menentukan kondisi tepat, kasus khusus, dan sumber yang mengatur bagaimana pasar ini diselesaikan.